Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis

Current options for treating tuberculosis (TB) that is resistant to rifampicin (RR-TB) are few, and regimens are often long and poorly tolerated. Following recent evidence from the TB-PRACTECAL trial countries are considering programmatic uptake of 6-month, all-oral treatment regimens. We used a Mar...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	PLOS global public health Jg. 2; H. 12; S. e0001337
Hauptverfasser:	Sweeney, Sedona, Berry, Catherine, Kazounis, Emil, Motta, Ilaria, Vassall, Anna, Dodd, Matthew, Fielding, Katherine, Nyang’wa, Bern-Thomas
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Public Library of Science (PLoS) 2022
ISSN:	2767-3375, 2767-3375
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!